Clinical Trials Browser

Terminated × linrodostat × Clear all

NCT03695250 2023-08-22

BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer

Phase 1/2 Terminated

8 enrolled 11 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT03519256 2023-06-01

CheckMate 9UT

Phase 2 Terminated

142 enrolled 20 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT02750514 2021-03-22

FRACTION-Lung

Phase 2 Terminated

295 enrolled 21 charts

Advanced Cancer